ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Impact of Anatomic Variation and Reconstructive Technique on Complications Following Living Liver Donor Transplantation – A Report from the A2ALL Consortium

    T. Baker,1 M. Zimmerman,2 B. Samstein,3 E. Pomfret,4 J. Pomposelli,4 C. Berg,5 N. Goodrich,6 B. Gillespie,7 J. Emond.3

    1Northwestern University, Chicago; 2University of Colorado, Denver; 3Columbia University, New York; 4Lahey Clinic, Burlington; 5Duke University, Durham; 6Arbor Research, Ann Arbor; 7University of Michigan, Ann Arbor.

    Introduction: Living donor liver transplantation [LDLT] is a technically demanding endeavor that requires command of the complex anatomy of partial liver grafts. The aim of…
  • 2015 American Transplant Congress

    The Higher MFI of De Novo Donor-Specific Anti-HLA Antibodies Is Correlated With Graft Fibrosis Progression in Living Donor Liver Transplantation

    Y. Fukasaku,1 R. Goto,1 S. Emoto,1 N. Kawamura,1 Y. Koshizuka,1 T. Takahashi,1 M. Ota,3 T. Aoyagi,1 K. Yamashita,2 A. Taketomi,1 T. Shimamura.3

    1Gastroenterological Surgery 1, Hokkaido University, Sapporo, Japan; 2Transplant Surgery, Hokkaido University, Sapporo, Japan; 3Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan.

    Background. It has been shown that the development of de novo donor-specific anti-HLA antibodies (DSA) is associated with poorer graft outcome in kidney transplantation. However…
  • 2015 American Transplant Congress

    Increased Ratio of Estimated Spleen/Graft Volume Is a Strong Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation: Significance of Splenectomy On Portal Venous Pressure and Patient Survival

    S. Mizuno, K. Gyoten, A. Tanemura, Y. Murata, H. Kato, N. Kuriyama, M. Kishiwada, M. Usui, H. Sakurai, S. Isaji.

    Hepatobiliary-Pancreatic and Transplant Surgery, Mie University, Tsu, Mie, Japan.

    Splenectomy is generally performed to control portal venous pressure (PVP) in adult-to-adult living donor liver transplantation (ALDLT) with small-for-size graft. However, we sometimes experience portal…
  • 2015 American Transplant Congress

    Impact of Pretransplant Sarcopenia and Sequential Changes in Sarcopenic Parameters After Living Donor Liver Transplantation

    T. Kaido,1 Y. Tamai,2 K. Ogawa,1 Y. Fujimoto,1 A. Mori,1 H. Okajima,1 N. Inagaki,2 S. Uemoto.1

    1Hepato-Biliary-Pancreatic and Transplant Surgery, Kyoto University, Kyoto, Japan; 2Metabolism and Clinical Nutrition, Kyoto University Hospital, Kyoto, Japan.

    The present study investigated the impact of pretransplant sarcopenia on survival and sequential changes in sarcopenic parameters in patients undergoing living donor liver transplantation (LDLT).…
  • 2015 American Transplant Congress

    Living Donor Liver Transplantation for Biliary Atresia has Equivalent Survival and Shorter Waiting Time Compared to Deceased Donor Liver Transplantation

    S. Alexopoulos,1 V. Nekrasov,1 L. Matsuoka,1 K. Chouliaras,2 Y. Genyk.1

    1Department of Surgery, Keck Medical Center of USC, Los Angeles, CA; 2Department of Surgery, Wake Forest University, Winston-Salem, NC.

    Purpose: To determine the benefit of living donor liver transplantation (LDLT) compared to deceased donor liver transplantation (DDLT) in the treatment of end stage liver…
  • 2015 American Transplant Congress

    Impact of Preoperative MELD Score On Small for Size Syndrome in Living Donor Liver Transplantation

    S. Marubashi, A. Tomokuni, Y. Tomimaru, T. Asaoka, H. Wada, H. Eguchi, K. Umeshita, Y. Doki, M. Mori, H. Nagano.

    Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

    Living donor liver transplantation (LDLT) has been expanded worldwide and the outcome of even adult-to-adult LDLT using left lobe reported to be equivalent to that…
  • 2015 American Transplant Congress

    Live Donor Liver Transplantation With Older (>50years) Vs Younger (<50years) Donors: Does Age Matter?

    N. Goldaracena, G. Sapisochin, J. Echeverri, M. Kaths, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, M. Selzner.

    Multi Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada.

    Introduction: The risks of living donor liver transplantation (LDLT) with older donors remains controversial and many centers avoid using live donors ≥45 years of age.…
  • 2015 American Transplant Congress

    Donor-Derived Tumor Transmission Events. A Summary of 2008-2013 Data from the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

    M. Nalesnik,1 S. Taranto,2 S. Covington,2 E. Blumberg,1 M. Green,1 T. Gross,1 M. Klassen-Fischer,1 M. Pavlakis,1 C. Wolfe,1 D. Kaul.1

    1OPTN Disease Transmission Advisory Committee (DTAC), Richmond, VA; 2United Network for Organ Sharing, Richmond, VA.

    Purpose: Transmission of donor malignancy via transplantation is an uncommon but significant occurrence. The OPTN Disease Transmission Advisory Committee (DTAC) has monitored such complications since…
  • 2015 American Transplant Congress

    Clinical and Virologic Outcomes in High-Risk Adult EBV D+/R- Organ Transplant Recipients

    D. Kumar, N. Patil, S. Husain, C. Chaparro, A. Humar.

    UHN, Toronto, Canada.

    Background:EBV D+/R- organ transplant recipients are a high risk group for developing PTLD. This subgroup of patients has been primarily evaluated in pediatric populations with…
  • 2015 American Transplant Congress

    Deficiency of Naturally Occurring Anti-Angiogenic Antibodies Associate With the Development of Metastatic Cancer Post Renal Transplantation and Patient Death

    R. Carroll,1 A. Phillippe,2 R. Catar,2 H. Heidecke,2 D. Dragun.2

    1Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia; 2Centre for Cardiovascular Research, Charite Hospital, Berlin, Germany.

    We assessed the presence of naturally occurring blocking antibodies to mediators of vascularisation and metastasis in Kidney Transplant Recipients (KTR) with metastatic cancer (n=11), non…
  • « Previous Page
  • 1
  • …
  • 1373
  • 1374
  • 1375
  • 1376
  • 1377
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences